Gentamicin nephrotoxicity - A comparison of In vitro findings with In vivo experiments in equines

Veterinary Research Communications

Volumn 29, Issue 3, 2005, Pages 247-261

  van der Harst, M R ^a   Bull, S ^a   Laffont, C M ^a   Klein, W R ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

glutamyl transferase; Dose regime; Gentamicin; Horses; Nephrotoxicity

Indexed keywords

BIOCHEMICAL MARKER; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GENTAMICIN; NEUTRAL RED; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; CELL VIABILITY; CLINICAL OBSERVATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOTOXICITY TEST; DRUG DOSE REGIMEN; ENZYME RELEASE; EXPERIMENTAL DESIGN; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HORSE DISEASE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE EPITHELIUM; MALE; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; SENSITIVITY AND SPECIFICITY; TOXICITY TESTING; URINARY EXCRETION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CELL SURVIVAL; CREATININE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENCE POLARIZATION IMMUNOASSAY; GAMMA-GLUTAMYLTRANSFERASE; GENTAMICINS; HORSES; KIDNEY TUBULES, DISTAL; KIDNEY TUBULES, PROXIMAL; LLC-PK1 CELLS; MALE; NEUTRAL RED; OXAZINES; REACTIVE OXYGEN SPECIES; SWINE; XANTHENES;

EQUIDAE;

EID: 8444242909     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:VERC.0000047492.05882.bb     Document Type: Article

References (34)

1. Brown, S.A., Newkirk, D.R., Hunter, R.P., Smith, G.G. and Sugimoto, K., 1990. Extraction methods for quantitation of GM residues from tissues using fluorescence polarization immunoassay. Journal of the Association of Official Analytical Chemists, 73, 479-483
2. Bull, S., Langezaal, L, Clothier, R. and Coecke, S., 2001. A genetically engineered cell-based system for detecting metabolism-mediated toxicity. Alternatives to Laboratory Animals, 29, 703-716
3. Choi, K.H., Kim, T.I., Chong, D.L., Lee, HY and Han, D.S., 2000. GM induced apoptosis of renal tubular epithelial (LLC-PK 1) cells. Korean Journal of Internal Medicine, 15, 218-223
4. Clarke, C.R., Lochner, F.K. and Bellamy, J., 1992. Pharmacokinetics of GM and antipyrine in the horse-effect of advancing age. Journal of Veterinary Pharmacology and Therapeutics, 15, 309-313
5. Cuzzocrea, S., Mazzon, E., Dugo, L., Serraino, L, Di Paola, R., Britti, D., De Sarro, A., Pierpaoli, S., Caputi, A., Masim, E. and Salvernini, D., 2002. A role for superoxide in GM-mediated nephropathy in rats. European Journal of Pharmacology, 450, 67
6. El Mouedden, M., Laurent, G., Mingeot-Leclereq, M.P. and Tulkens, P.M., 2000. GM-induced apoptosis in renal cell lines and embryonic rat fibroblasts. Toxicological Sciences, 56, 229-239
7. Frame, P.T., Phair, J.P., Watanakunakorn, C. and Bannister, T.W, 1977. Pharmacologic factors associated with GM nephrotoxicity in rabbits. Journal of Infectious Diseases, 135, 952-956
8. Freeman, C.D., Nicolau, D.P., Belliveau, P.P. and Nightingale, C.H., 1997. Once-daily dosing of aminoglycosides: Review and recommendations for clinical practice. Journal of Antimicrobial Chemotherapy, 39 677-686
9. Gilbert, D.N., 1991. Once-daily aminoglycoside therapy. Antimicrobial Agents and Chemotherapy, 35, 399-405
10. Godber, L.M., Walker, R.D., Stein, G.E., Hauptman, J.G. and Derksen, F.J., 1995. Pharmacokinetics, nephrotoxicosis, and in vitro antibacterial activity associated with single versus multiple (three times) daily GM treatments in horses. American Journal of Veterinary Research, 56, 613-618
11. Haddad, N.S., Pedersoli, W.M., Ravis, W.R., Fazeli, M.H. and Carson, R.L. Jr., 1985. Combined pharmacokinetics of GM in pony mares after a single intravenous and intramuscular administration. American Journal of Veterinary Research, 46, 2004-2007
12. Hinchcliff, K.W., McGuirk, S.M., MacWilliams, P.S. and Cooley, A.J., 1989. Phenolsulfonphthalein pharmacokinetics and renal morphologic changes in adult pony mares with GM-induced nephrotoxicosis. American Journal of Veterinary Research, 50, 1848-1853
13. Houghton, D.C., Lee, D., Gilbert, D.N. and Bennett, W.M., 1986. Chronic GM nephrotoxicity. Continued tubular injury with preserved glomerular filtration function. American Journal of Pathology, 123, 183-194
14. Jedeikin, R., Dolgunski, E., Kaplan, R. and Hoffman, S., 1987. Prolongation of neuromuscular blocking effect of vecuronium by antibiotics. Anaesthesia, 42, 858-860
15. Khand, F.D., Gordge, M.P., Robertson, W.G., Noronha-Dutra, A.A. and Hothersall, J.S., 2002. Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells. Free Radical Biology and Medicine, 32, 1339-1350
16. Lippmann, M., Yang, E., An, E. and Lee, C., 1982. Neuromuscular blocking effects of tobramycin, GM, and cefazolin. Anesthesia and Analgesia, 61, 767-770
17. Magdesian, K.G., Hogan, P.M., Cohen, N.D., Brumbaugh, G.W. and Bernard, W.V., 1998. Pharmacokinetics of a high dose of GM administered intravenously or intramuscularly to horses. Journal of the American Veterinary Association, 213, 1007-1011
18. Martin-Jimenez, T., Papich, M.G. and Riviere, J.E., 1998. Population pharmacokinetics of GM in horses. American Journal of Veterinary Research, 59, 1589-1598
19. Mattie, H., Craig, W.A. and Pechere, J.C., 1989. Determinants of efficacy and toxicity of aminoglycosides. Journal of Antimicrobial Chemotherapy, 24, 281-293
20. Mukherjee, A.K., Ghosal, S.K. and Maity, C.R., 1997. Lysosomal membrane stabilization by alphatocopherol against the damaging action of Vipera russelli venom phospholipase A2. Cellular and Molecular Life Sciences, 53, 152-155
21. Nicolau, D.P., Freeman, C.D., Belliveau, P.P., Nightingale, C.H., Ross, JW. and Quintiliani, R., 1995. Experience with a once-daily aminoglycoside program administered to 2184 adult patients. Antimicrobial Agents and Chemotherapy, 39, 650-655
22. Pedraza-Chaverri, J., Granados-Silvestre, M.D., Medina-Campos, O.N. and Hernandez-Pando, R., 1999. Effect of the in vivo catalase inhibition on aminonucleoside nephrosis. Free Radical Biology and Medicine, 27, 245-253
23. Perrier, D. and Gibaldi, M., 1982. General derivation of the equation for time to reach a certain fraction of steady state. Journal of Pharmaceutical Sciences, 71, 474-475
24. Powell, S.H., Thompson, WL., Luthe, M.A., Stern, R.C., Grossniklaus, D.A., Bloxham, D.D., Groden, D.L., Jacobs, MR., DiScenna, A.O., Cash, H.A. and Klinger, J.D., 1983. Once-daily vs. continuous aminoglycoside dosing: Efficacy and toxicity in animal and clinical studies of GM, netilmicin, and tobramycin. Journal of Infectious Diseases, 147, 918-932
25. Prins, J.M., Buller, H.R., Kuijper, E.J., Tange, R.A. and Speelman, P., 1993. Once versus thrice daily GM in patients with serious infections. Lancet, 341, 335-339
26. Riviere, J.E., Coppoe, G.L., Hinsman, E.J., Carlton, WW. and Traver, D.S., 1983a. Species dependent GM pharmacokinetics and nephrotoxicity in the young horse. Fundamental and Applied Toxicology, 3, 448-457
27. Riviere, J.E., Hinsman, E.J., Coppoe, G.L., Carlton, W.W. and Traver, D.S., 1983b. Morphological and functional aspects of experimental GM nephrotoxicity in young beagles and foals. Veterinary Research Communications, 7, 211-213
28. Rutten, J.M., Booij, L.H., Rutten, C.L. and Crul, J.F., 1980. The comparative neuromuscular blocking effects of some arninoglycoside antibiotics. Acta Anaesthesiologica Belgica, 31, 293-306
29. Sener, G., Sehirli, A.O., Altunbas, H.Z., Ersoy, Y, Paskaloglu, K., Arbak, S. and Ayanoglu-Dulger, G., 2002. Melatonin protects against GM-induced nephrotoxicity in rats. Journal of Pineal Research, 32, 231-236
30. Trayner, I.D., Rayner, A.P., Freeman, G.E. and Farzaneh, F., 1995. Quantitative multiwell myeloid differentiation assay using dichlorodihydrofluorescein diacetate (H2DCF-DA) or dihydrorhodamine 123 (H2RI23). Journal of Immunological Methods, 186, 275-284
31. Tudor, R.A., Papich, M.G. and Redding, WR., 1999. Drug disposition and dosage determination of once daily administration of GM sulfate in horses after abdominal surgery. Journal of the American Veterinary Medical Association, 215, 503-506
32. Walker, P.D., Barri, Y and Shah, SY., 1999. Oxidant mechanisms in GM nephrotoxicity. Renal Failure, 21, 433-442
33. Yamaoka, K., Nakagawa, T. and Uno, T., 1978. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6 165-175
34. Yamaoka, K., Tanigawara, Y., Nakagawa, T. and Uno, T., 1981. A pharmacokinetic analysis program (multi) for microcomputer. Journal of Pharmacobiodynamics, 4, 879-885